<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): November 8, 2000
HYPERTENSION DIAGNOSTICS, INC.
(Exact name of Registrant as specified in its charter)
Minnesota 0-24635 41-1618036
---------------------------- ------------------------ ------------------
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
2915 Waters Road, Suite 108
Eagan, Minnesota 55121
--------------------------- ------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 651-687-9999
<PAGE> 2
Items 1, 2, 3, 4, 6, 7 and 8 are not applicable and therefore omitted.
ITEM 5. OTHER EVENTS.
Incorporated herein is the attached copy of the press release dated
November 8, 2000 pertaining to the Company's discussion of potential revenues
for fiscal year 2001, including the timing of the possible commencement of the
receipt of revenues related to the marketing of the Company's CVProfilor(TM)
DO-2020 CardioVascular Profiling System.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
HYPERTENSION DIAGNOSTICS, INC.
By /s/ James S. Murphy
---------------------------------------
Its Senior Vice President, Finance and
Administration and Chief Financial Officer
Dated: November 9, 2000
1282329
